Why A Diet Heavy in Fruits and Vegetables Might Help Men With Prostate Cancer

Many people consider food diet important in both prostate cancer prevention and in controlling its progression. Dietary derived agents, such as the flavonoids derived from fruits and vegetables should be of particular interest for prostate cancer survivors, as they seem to offer both chemo-prevention and an antioxidant effect along with a favorable safety and side-effect [...]

Payment for PSA Prostate Cancer Screening may end

Believe it or not, in this week approaching Thanksgiving, we in the United States are faced with a second challenge to Prostate Cancer screening using the PSA test. Malecare wants you to know.   The Centers for Medicare and Medicaid Services (CMS) is asking for pubic comment on a clinical quality measure that would probably [...]

By |2021-02-22T10:05:35-05:00November 15th, 2015|Advanced Prostate Cancer, Advocacy, Uncategorized|0 Comments

Malecare Issued Patent For A Device and Method Which Can Reduce Secondary Tumors from Radiation Therapy

On October 27, 2015, Malecare was issued patent 9,168,002 for a device and method for real time simultaneous measurement of radiation at specific parts of your body,. Understanding cumulative radiation exposure in people undergoing ionizing radiation for diagnostics and medical treatment is essential towards reducing secondary tumors from primary radiation therapy.   We believe that the [...]

On The Horizon – Tests That Can Inform Us If A Drug Will Work Before We Take The Drug

We have become very fortunate over the last 6 years because our arsenal of potential drugs to treat advanced, metastatic prostate cancer has grown. All of our new drugs extend life and most offer palliation of pain. As I have discussed in prior posts we are still in a quandary about how best to sequence [...]

USPSTF Responds to Malecare’s Questions regarding PSA Screening

Malecare sent questions to Albert Siu, MD, Chairperson of the U.S. Preventive Services Task Force about plans to review their 2012 recommendation against the use of the PSA test for prostate cancer screening.  We thought that this information would be important since the USPTF is currently soliciting public comments on the research design of their review [...]

By |2021-02-17T10:23:50-05:00November 11th, 2015|Advanced Prostate Cancer, Advocacy, PSA, Uncategorized, USPTF|0 Comments
Go to Top